About us

Vision

ImageCyte’s vision is to enable more reliable and scalable biological discovery by improving how cells, organoids, and model organisms are prepared for imaging. Through precision nanowell technology, ImageCyte provides simple, compatible tools that enhance imaging quality, reproducibility, and throughput, supporting deeper insight into cellular phenotypes and biological mechanisms.

Mission

Empowering cell research through simple, scalable cell isolation technologies designed for high-quality imaging and analysis.

Our Approach

ImageCyte’s development philosophy is grounded in close collaboration with end users. Plate designs are informed by real experimental workflows, with an emphasis on compatibility, reproducibility, and ease of adoption.

Rather than replacing existing instrumentation or analysis pipelines, ImageCyte focuses on improving the physical interface between biological samples and imaging systems—where many sources of variability originate. This approach enables researchers to extract higher-quality data from experiments they already know how to run.

Our Team

Samuel Berryman, PhD

CEO, co-founder

Hong Ma, PhD

CSO, co-founder

Kyle Briggs, PhD

Start-up Advisor

Chang Han

Corporate Advisor

Gabe Kalmar, PhD

Operations Advisor

Malcolm Kendall, MBA

Venture Capital Advisor

Sales & Marketing Advisor

Michele Wallcraft